血管假性血友病因子/血管性血友病因子抗体
Von Willebrand Factor; Coagulation factor VIII; F8VWF; Factor VIII related antigen; von Willebrand antigen 2; Von Willebrand antigen II; Von Willebrand disease; VWD; VWF; VWF_HUMAN.
生长分化因子3抗体
GDF 3; GDF-3; GDF3; GDF3_HUMAN; Growth differentiation factor 3; Growth/differentiation factor 3; Vgr 2; Vgr2; C78318; ecat9; MGC123990; MGC123991.
核因子1A抗体
CCAAT binding transcription factor; CCAAT Box Binding Transcription Factor; CCAAT-box-binding transcription factor; CTF; FLJ39164; NF I/A; NF-I/A; NF1 A; NF1-A; NF1A; NFI A; NFI L; NFI-A; NFIA; NFIA_H
Anti-CPSF3L Polyclonal Antibody
Anti-CPSF3L Polyclonal Antibody应用 IHC 稀释比例 IHC 1:50-200. 交叉反应 Human Mouse
转录共激活因子130抗体
130 kDa transcriptional co activator; 133 kDa transcriptional co activator; Activator recruited cofactor 130 kDa component; Activator-recruited cofactor 130 kDa component; ARC 130; ARC130; Cofactor re
转录因子LMCD1抗体
Dyxin; LIM and cysteine rich domains 1; LIM and cysteine rich domains protein 1; LIM and cysteine-rich domains protein 1; LMCD1_HUMAN.
Anti-GAPDH(Human specific) 单克隆抗体
Anti-GAPDH(Human specific) Monoclonal Antibody 应用 WB 稀释比例 WB 1:5000. 蛋白分子量 36kDa
转录调节因子C/EBPγ抗体
C/EBP gamma; CCAAT/enhancer binding protein (C/EBP) gamma; CCAAT/enhancer binding protein gamma; CEBPG; GPE1BP; IG/EBP 1; IG/EBP1; CEBPG_HUMAN.